Adaptimmune is a fully integrated cell therapy company, designed and built from the ground up with four U.K.- and U.S.-based biotechnology hub locations. Our comprehensive capabilities and teams include preclinical research, clinical development, translational sciences, autologous and allogeneic manufacturing, and in-house commercial and corporate operations. For more information about Adaptimmune, please visit www.adaptimmune.com. If interested in joining our fast growing team, click on the careers tab of this page.
View Top Employees from AdaptimmuneWebsite | http://www.adaptimmune.com |
Ticker | ADAP |
Revenue | $59 million |
Funding | $485.9 million |
Employees | 507 (507 on RocketReach) |
Founded | 2008 |
Phone | +44 1235 430000 |
Technologies |
JavaScript,
HTML,
Twitter
+79 more
(view full list)
|
Industry | Biotechnology Research, Drug Manufacturing & Research, Biopharma, Other Commercial Services, Pharmaceuticals, Biotechnology, Healthcare, Health Care, Science and Engineering, Medical |
Web Rank | 3 Million |
Keywords | Cell Therapies, Immunotherapy, Cancer Treatment |
Competitors | CBMG Holdings, Immatics, Juno Therapeutics, Inc., Kite Pharma, Sorrento Therapeutics, Inc. |
SIC | SIC Code 28 Companies, SIC Code 2835 Companies, SIC Code 283 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 541714 Companies, NAICS Code 5417 Companies, NAICS Code 541 Companies, NAICS Code 54 Companies, NAICS Code 54171 Companies |
Looking for a particular Adaptimmune employee's phone or email?
The Adaptimmune annual revenue was $59 million in 2024.
507 people are employed at Adaptimmune.
The NAICS codes for Adaptimmune are [541714, 5417, 541, 54, 54171].
The SIC codes for Adaptimmune are [28, 2835, 283, 87].